Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen - ChAd3-EBO-Z followed by MVA-EBO-Z in healthy adults in the UK and Senegal
published in: Journal of Infectious Diseases
date of publication: 2019-04-01
language: English
main subject: Ebola virus, Senegal
Cites articles 25
- 2017-08-02
Date
Title
Article - wd:Q58583417